JUN 15, 2020 3:18 PM PDT

Experimental MS Treatment Relies on "Retraining" the Immune System

WRITTEN BY: Kara Marker

When the immune system goes awry and fails to regulate itself, immune cells may attack the body’s own tissues. Scientists want to prevent immune cells from going rogue by teaching them the “proper” way to behave.

A normal immune response has a regulatory component that keeps the immune system focused on an outside invader and away from targeting its own cells (“self” cells). However, that regulatory system can be compromised, leading to autoimmune disease.

In the case of multiple sclerosis (MS), the self cells under attack are those that make up myelin proteins, a fatty sheath of tissue that covers and protect nerves. With the myelin sheath under attack, the body has less control over muscles and subsequently, movement. Scientists leading the new study aimed to correct cells’ self-destructive behavior to prevent damaging tissues like the myelin sheath.

In a two-part study, researchers looked at the T cell mechanisms that control the immune system and how their behavior can be manipulated with longevity in mind. The goal was to help T cells recognize Myelin Basic Protein (MBP) properly, as belonging to the body, thus avoiding the “friendly fire” that characterizes autoimmune diseases like MS.

In part one, researchers treated the immune system with repeated doses of the same “highly soluble fragment” of MBP. The process is similar to immunotherapy used to desensitize the immune system to reduce allergic responses. Researchers found success in part one; results showed that T cells successfully learned to recognize MBP and cease attacking it.

In part two, researchers observed how genes in T cells can be altered as a result of the therapeutic process in part one. The treatment effectively activated genes that reduce immune activity as opposed to increasing it, enhancing appropriate “tolerance” of self cells. Researchers also found that cells could “remember” the behavior change, and the gene activity reflected that memory.

Future clinical trials are needed to indicate long-lasting effects for people with MS. What causes MS is still unknown. Individuals diagnosed with MS tend to follow one of four disease courses:

  1. Clinically isolated syndrome
  2. Relapsing remitting
  3. Secondary progressive
  4. Primary progressive

Sources: University of Birmingham, Cell Reports, National Multiple Sclerosis Society

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 31, 2021
Microbiology
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
MAR 31, 2021
Deep-Sea Microbes Are 'Invisible' to the Human Immune System
Scientists took an exploratory journey to a place in the central Pacific Ocean in Kirbati called the Phoenix Islands Pro ...
APR 08, 2021
Immunology
It's Not Just Cholesterol That Clogs Arteries
APR 08, 2021
It's Not Just Cholesterol That Clogs Arteries
Researchers have discovered a gene that is directly linked to the development of cardiovascular diseases, such as high b ...
APR 05, 2021
Cancer
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
APR 05, 2021
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
A team from the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center is introdu ...
MAY 19, 2021
Drug Discovery & Development
Combination Immunotherapy Shows Promise in Treating HIV
MAY 19, 2021
Combination Immunotherapy Shows Promise in Treating HIV
  Researchers have found that a new combination immunotherapy, alongside antiretroviral therapy (ART), is effective ...
JUL 15, 2021
Immunology
Your Immune System Can't Deal With All the Plastic You're Eating
JUL 15, 2021
Your Immune System Can't Deal With All the Plastic You're Eating
Microplastics—tiny fragments of plastic, less than five millimeters in diameter—pollute our environment and, ...
JUL 29, 2021
Drug Discovery & Development
What is Ivermectin and Can it Treat COVID?
JUL 29, 2021
What is Ivermectin and Can it Treat COVID?
Lab tests in 2020 found that the widely available drug ivermectin had a weak effect on the SARS-CoV-2 virus and that unf ...
Loading Comments...